,User Defined ID,Criterion,Criterion Category
0,PMID35915094_inexcl-01,SARS-CoV-2 Antibodies Measured,inclusion
1,PMID33915337_inexcl-01,Pediatric subjects,Inclusion
2,PMID34047304_inexcl-01,Patients with Crohnâ€™s disease,Inclusion
3,PMID34047304_inexcl-02,Patients with Ulcerative/indeterminate colitis,Inclusion
4,PMID34047304_inexcl-03,Geriatric subjects,inclusion
5,PMID34047304_inexcl-04,Pediatric subjects,exclusion
6,PMID35877413_inexcl-01,SARS-CoV-2 Antibodies Measured,Inclusion
7,PMID35877413_inexcl-02,Geriatric subjects,Inclusion
8,PMID35877413_inexcl-03,WHO disease severity scale used,Inclusion
9,PMID35632708_inexcl-01,Not Applicable ,Inclusion
10,PMID35092678_inexcl-01,Not Applicable ,Inclusion
11,PMID34706273_inexcl-01,SARS-CoV-2 Antibodies Measured,Inclusion
12,PMID34706273_inexcl-02,Geriatric subjects,Inclusion
13,PMID34706273_inexcl-03,Fully vaccinated multiple myeloma patients,Inclusion
14,PMID34253053_inexcl-01,SARS-CoV-2 Antibodies Measured,inclusion
15,PMID35289114_ie-01,SARS-CoV-2 Antibodies Measured,Inclusion
16,PMID35795812_inexcl-01,Mathematical Model,Inclusion
